Insiders · Profile

PETERS KEVIN G.

Chief Scientific Officer at Whitehawk Therapeutics. Filing since 15 Mar 2017. CIK 0001700663

Company
Date
Role
Action
Shares
Amount
Of holding
15 Mar 2017
Chief Scientific Officer
Bought
3,642
$18.21K
1.1%
1 decision on file.